Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak

BACKGROUND: Finite clinical data and understanding of COVID-19 immunopathology has led to limited, opinion-based recommendations for the management of patients with immune-mediated inflammatory disease (IMID) receiving immunosuppressive (IS) therapeutics. OBJECTIVE: To determine if IS therapeutic ty...

Descripción completa

Detalles Bibliográficos
Autores principales: Veenstra, Jesse, Buechler, Connor R., Robinson, Gabrielle, Chapman, Stephanie, Adelman, Madeline, Tisack, Aaron, Dimitrion, Peter, Todter, Erika, Kohen, Laurie, Lim, Henry W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385924/
https://www.ncbi.nlm.nih.gov/pubmed/32735965
http://dx.doi.org/10.1016/j.jaad.2020.07.089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385924/
https://www.ncbi.nlm.nih.gov/pubmed/32735965
http://dx.doi.org/10.1016/j.jaad.2020.07.089

Ejemplares similares